Cancer Screening Utilization Rates and Cancer Screening Perspectives of Hospitalized Women

Sponsor

Johns Hopkins University (Other)

Overall Status

Active, not recruiting

CT.gov ID

NCT04162925

Collaborator

State of Maryland (Other)

700

Enrollment

Arm

Anticipated Duration (Months)

Study Details

Study Description

Brief Summary

Breast and colon cancers are commonly diagnosed cancers among women after skin cancer in Maryland. Patients' preferences for cancer screening are known to significantly influence utilization, and thus impact health outcomes. In a recent study the investigators conducted at Johns Hopkins Bayview Medical Center, the investigators observed that among women age 50-75 years admitted to general medicine services over 4-month period, 40% were non-adherent to breast cancer screening (overdue) despite being insured.

Therefore, the investigators propose to establish a cohort of hospitalized women to help the investigators develop successful interventions for enhancing breast cancer screening utilization in this group. In following a cohort prospectively, the investigators intend to both reaffirm the results from the investigators' previous study and determine whether the patterns of mammographic screening improve over time as a result of the investigators' interventions. Among non-adherent (overdue) women, the investigators will educate and encourage these women to undergo outpatient screening mammography.

To more comprehensively assess the preventive health in this cohort, the investigators will assess the cohort's adherence to colon cancer screening recommendation and barriers to colon cancer screening.

In addition the investigators will also like to encourage the hospitalists and house staff taking care of these patients to perform oral cancer screen among women who smoke (non-adherent to breast cancer screening) Finally the investigators will also like to ask the perspective of cancer screening among these women.

Condition or Disease	Intervention/Treatment	Phase
Cancer Screening	Behavioral: Cancer screening education for breast, colon and oral cancers	N/A

Study Design

Study Type:

Interventional

Actual Enrollment :

700 participants

Allocation:

N/A

Intervention Model:

Single Group Assignment

Intervention Model Description:

Cancer screening utilization rates and cancer screening perspective of hospitalized women on internal medicine serviceCancer screening utilization rates and cancer screening perspective of hospitalized women on internal medicine service

Masking:

None (Open Label)

Primary Purpose:

Health Services Research

Official Title:

Cancer Screening Utilization Rates and Cancer Screening Perspectives of Hospitalized Women

Actual Study Start Date :

Dec 1, 2014

Actual Primary Completion Date :

Dec 1, 2017

Anticipated Study Completion Date :

Dec 1, 2022

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Cancer screening cohort All women in this study to be evaluated for cancer screening utilization rates (breast, colon and oral cancers) and cancer screening perspectives of these hospitalized women. The intervention will be a cancer screening education.	Behavioral: Cancer screening education for breast, colon and oral cancers Bedside education one-on-one by showing screening video and handouts at the end of educational session for breast, colon and oral cancer. Patient who are agreeable to oral cancer screen during hospitalization perform oral cancer screening

Arm

Intervention/Treatment

Experimental: Cancer screening cohort

All women in this study to be evaluated for cancer screening utilization rates (breast, colon and oral cancers) and cancer screening perspectives of these hospitalized women. The intervention will be a cancer screening education.

Behavioral: Cancer screening education for breast, colon and oral cancers

Bedside education one-on-one by showing screening video and handouts at the end of educational session for breast, colon and oral cancer. Patient who are agreeable to oral cancer screen during hospitalization perform oral cancer screening

Outcome Measures

Primary Outcome Measures

Proportion of women non-adherent to breast cancer screening in this group [3 years]
Proportion of women non-adherent to breast cancer screening will be assessed in these hospitalized women.
Prevalence of breast cancer screening post intervention in this group [3 years]
Prevalence of breast cancer screening post intervention will be assessed in these hospitalized women.
Proportion of hospitalized women non-adherent to colon cancer screening [3 years]
Proportion of hospitalized women non-adherent to colon cancer screening will be assessed in these hospitalized women.
Perspective of hospitalized women about colon cancer screening as assessed by multiple choice questions [3 years]
survey of hospitalized women using multiple choice 21 questions
Perspective of hospitalized women about colon cancer screening as assessed by likert scale 21 questions [3 years]
survey of hospitalized women using likert scale 21 questions
Proportion of women non-adherent to oral cancer screening [3 years]
Proportion of women non-adherent to oral cancer screening will be assessed in these hospitalized women.
Number of women agreeable to inpatient oral cancer screening exam [3 years]
oral cavity screening exam consisting of mouth and neck examination by hospital providers
Perspective of hospitalized women in general about their preference for cancers screening as assessed by multiple choice questions [3 years]
a survey consisting of 55 multiple choice questions
Perspective of hospitalized women in general about their preference for cancers screening as assessed by likert scale [3 years]
a survey with a likert scale

Eligibility Criteria

Criteria

Ages Eligible for Study:

50 Years to 75 Years

Sexes Eligible for Study:

Female

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

Women between the ages of 50 to 75 years admitted to medicine service at Johns Hopkins Bayview Medical Center
cancer free at baseline (excluding skin cancers)
willing to participate voluntarily

Exclusion Criteria:

history of breast cancer or mastectomy
history of other cancers (except skin) or serious comorbidities making life expectancy <10 years
pregnancy
dementia
chronic disability (unable to stand or nursing home resident)
current admission because of acute coronary event (heart attack) or stroke or pulmonary embolism
chronic kidney disease on hemodialysis
history of BRCA1 or BRCA2 gene mutation
current admission for cellulitis or abscess of breast

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

Johns Hopkins University
State of Maryland

Investigators

Principal Investigator: Waseem Khaliq, MD, Johns Hopkins University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Johns Hopkins University

ClinicalTrials.gov Identifier:

NCT04162925

Other Study ID Numbers:

IRB00049608
IO90059879

First Posted:

Nov 14, 2019

Last Update Posted:

Dec 30, 2021

Last Verified:

Dec 1, 2021

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Study Results

No Results Posted as of Dec 30, 2021